Advances in the Management of Pemphigus Vulgaris: A Review Article

Advances in the Management of Pemphigus Vulgaris: A Review Article

Rahaf Alhabbab

Contact

Reshale Johar

Contact

Advances in the Management of Pemphigus Vulgaris: A Review Article

Article Fingerprint

ReserarchID

0573Y

Advances in the Management of Pemphigus Vulgaris: A Review Article Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

37 Cites in Article

Reference Format

Jean-Claude Bystryn (1996). The Adjuvant Therapy of Pemphigus.
Kyriakos Kyriakis Md,Androniki Tosca Md (1998). Epidemiologic observations on the natural course of pemphigus vulgaris.
D Kuriachan,R Suresh,M Janardhanan,V Savithri (2015). Oral lesions: The Clue to Diagnosis of Pemphigus Vulgaris.
A Gambino,M Carbone,P Arduino,P Carcieri,L Carbone,R Broccoletti (2014). Conservative Approach in Patients with Pemphigus Gingival Vulgaris: A Pilot Study of Five Cases.
P Joly,N Litrowski (2011). Pemphigus Group (Vulgaris, Vegetans, Foliaceus, Herpetiformis, Brasiliensis).
S Pisanti,Y Sharav,E Kaufman,L Posner (1974). Pemphigus vulgaris: Incidence in Jews of different ethnic groups, according to age, sex, and initial lesion.
Sara Wertenteil,Amit Garg,Andrew Strunk,Allireza Alloo (2019). Prevalence Estimates for Pemphigus in the United States.
David Garrod,Martyn Chidgey (2008). Desmosome structure, composition and function.
P Joly,B Horvath,Α Patsatsi,S Uzun,R Bech,S Beissert,R Bergman,P Bernard,L Borradori,M Caproni,F Caux,G Cianchini,M Daneshpazhooh,D De,M Dmochowski,K Drenovska,J Ehrchen,C Feliciani,M Goebeler,R Groves,C Guenther,S Hofmann,D Ioannides,C Kowalewski,R Ludwig,Y Lim,B Marinovic,A Marzano,J Mascaró,D Mimouni,D Murrell,C Pincelli,C Squarcioni,M Sárdy,J Setterfield,E Sprecher,S Vassileva,K Wozniak,S Yayli,G Zambruno,D Zillikens,M Hertl,E Schmidt (2020). Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).
Msendhil Kumaran,Amrinder Kanwar,Divya Seshadri (2013). Acantholysis revisited: Back to basics.
M Kavala,S Altıntaş,E Kocatürk,İ Zindancı,B Can,Ç Ruhi,Z Turkoglu (2011). Ear, nose and throat involvement in patients with pemphigus vulgaris: correlation with severity, phenotype and disease activity.
Mukaddes Kavala,Filiz Topaloğlu Demir,Ilkin Zindanci,Burce Can,Zafer Turkoğlu,Ebru Zemheri,Osman Cam,Ahmet Teksen (2015). Genital involvement in pemphigus vulgaris (PV): Correlation with clinical and cervicovaginal Pap smear findings.
Sentamilselvi Ganapati (2014). Eponymous dermatological signs in bullous dermatoses.
William James,Dirk Elston,Patrick Mcmahon (2005). Chronic Blistering Dermatoses.
S Cheng,M Kobayashi,A Tanikawa,K Kinoshita-Kuroda,M Amagai,T Nishikawa (2002). Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
M Daneshpazhooh,Zafarmand Sedigh,V Balighi,K (2016). Immunologic Prediction of Relapse in Patients with Pemphigus Vulgaris (PV) in Clinical Remission.
M Saleh (2018). A Prospective Study Comparing Patients with Early and Late Relapsing Pemphigus Treated with Rituximab.
Jean-Claude Bystryn,Jennifer Rudolph (2005). Pemphigus.
Ronald Moy,Robert Jordon (1983). Immunopathology in pemphigus.
M Pfutze,A Niedermeier,M Hertl,R Eming (2007). Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.
Dedee Murrell,Sarah Dick,A Ahmed,Masayuki Amagai,Maria Barnadas,Luca Borradori,Jean-Claude Bystryn,Giuseppe Cianchini,Luis Diaz,David Fivenson,Russell Hall,Karen Harman,Takashi Hashimoto,Michael Hertl,Nico Hunzelmann,Pilar Iranzo,Pascal Joly,Marcel Jonkman,Yasuo Kitajima,Neil Korman,Linda Martin,Daniel Mimouni,Amit Pandya,Aimee Payne,David Rubenstein,Hiroshi Shimizu,Animesh Sinha,David Sirois,Detlef Zillikens,Victoria Werth (2008). Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.
Benjamin Daniel,Michael Hertl,Victoria Werth,Rüdiger Eming,Dédée Murrell (2012). Severity score indexes for blistering diseases.
Cheyda Chams-Davatchi,Nafiseh Esmaili,Maryam Daneshpazhooh,Mahin Valikhani,Kamran Balighi,Zahra Hallaji,Masoumeh Barzegari,Maryam Akhyani,S Ghodsi,Hassan Seirafi,Mohammad-Javad Tabrizi Nazemi,Hossein Mortazavi,Mostafa Mirshams-Shahshahani (2007). Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Jean-Claude Bystryn (1996). The Adjuvant Therapy of Pemphigus.
William Sanders (2017). A brief review of pemphigus vulgaris.
S Meggitt,A Anstey,M Mohd Mustapa,N Reynolds,S Wakelin,M Tidman,L Fuller,J Mclelland,J Lear,J Hughes,A Mcdonagh,S Punjabi,N Morar,D Buckley,I Nasr,P Maycock,S Amin,S Hulley,S Haveron (2011). British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011.
O Mohammadi,T Kassim (2021). StatPearls [Internet.
Robert Weinstein (2012). Glucocorticoid-Induced Osteoporosis and Osteonecrosis.
Y Puckett,A Gabbar,A Bokhari (2021). StatPearls [Internet.
S Treon,K Anderson (2000). The Use of Rituximab in the Treatment of Malignant and Nonmalignant Plasma Cell Disorders.
M Arin,A Engert,T Krieg,N Hunzelmann (2005). Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
Victoria Werth,Pascal Joly,Daniel Mimouni,Emanual Maverakis,Frédéric Caux,Patricia Lehane,Liudmila Gearhart,Audrey Kapre,Pooneh Pordeli,Diana Chen (2021). Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Lauren Albers,Yuan Liu,Na Bo,Robert Swerlick,Ron Feldman (2017). Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab.
G Genovese,C Maronese,G Casazza,L Corti,L Venegoni,S Muratori,E Berti,D Fanoni,A Marzano (2022). Clinical and serological predictors of relapse in pemphigus: a study of 143 patients.
Maud Maho-Vaillant,Corine Perals,Marie-Laure Golinski,Vivien Hébert,Frédérique Caillot,Claire Mignard,Gaëtan Riou,Marie Petit,Manuelle Viguier,Michael Hertl,Olivier Boyer,Sébastien Calbo,Nicolas Fazilleau,Pascal Joly (2021). Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus.
A Dupuy,M Viguier,C Et Bedane,Al (2004). Treatment of Refractory Pemphigus Vulgaris with Rituximab (Anti-CD20 Monoclonal Antibody).
O Benjamin,P Bansal,A Goyal,S Lappin (2021). StatPearls [Internet.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Rahaf Alhabbab. 2026. \u201cAdvances in the Management of Pemphigus Vulgaris: A Review Article\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 22 (GJMR Volume 22 Issue F7): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 22 Issue F7
Pg. 5- 8

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-F Classification: DDC Code: 616.978 LCC Code: QR186

Submission ReceivedJuly 26, 2022
Peer Review Double Blind
Handling Editor
Accepted August 1, 2022
Published September 3, 2022

Version of record

v1.2

Issue date

September 17, 2022

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 1543

Total Downloads: 65

2026 Trends

Published Article

Abstract not found

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]